Wednesday, July 14, 2021

Pharma Reviews: API is a decadal Opportunity for Indian Pharma Sector: Sudarshan Jain, Apax Partners

Sudharshan Jain speaks to ET NOW about the Indian Pharma industry especially with regard to API manufacturing, the Government's PLI scheme and ...
Read more: API is a decadal Opportunity for Indian Pharma Sector: Sudarshan Jain, Apax Partners